What does a high Standardized Uptake Value (SUV) on a Positron Emission Tomography (PET) scan indicate?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: June 25, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

From the Guidelines

A high Standardized Uptake Value (SUV) on a Positron Emission Tomography (PET) scan typically indicates increased metabolic activity in the tissue being examined, which often suggests the presence of malignancy or active inflammation, as supported by the most recent study 1. This value represents the concentration of the radiotracer (usually fluorodeoxyglucose or FDG) in a specific area compared to what would be expected in normal tissue.

  • Cancer cells generally consume more glucose than normal cells due to their rapid growth and altered metabolism, leading to greater uptake of FDG and consequently higher SUV measurements.
  • However, it's essential to understand that high SUV values are not exclusively indicative of cancer, as various non-malignant conditions such as infections, inflammation, healing fractures, and even normal physiological processes in organs like the brain, heart, and urinary tract can also demonstrate elevated SUV readings. The interpretation of SUV values must always be considered in the clinical context of the patient, including their medical history, symptoms, and results from other diagnostic tests, as highlighted in 1 and 1. SUV measurements are particularly valuable for monitoring treatment response in cancer patients, where decreasing values often correlate with effective therapy, as noted in 1. Some key points to consider when interpreting SUV values include:
  • The clinical context of the patient
  • The presence of non-malignant conditions that may cause elevated SUV readings
  • The use of SUV measurements in conjunction with other diagnostic tests
  • The potential for false-positive or false-negative results, as discussed in 1 and 1.

From the Research

Standardized Uptake Value (SUV) on PET Scan

  • A high Standardized Uptake Value (SUV) on a Positron Emission Tomography (PET) scan indicates increased fluoro-deoxyglucose (FDG) uptake by a tumor, which can be associated with aggressive tumor behavior 2.
  • Studies have shown that SUVs are correlated with clinicopathological factors such as mitotic counts, Ki67 positive cell percentage, and nuclear grade, reflecting cellular aggressiveness 2.
  • A maximum FDG uptake of >10 SUV seems to significantly correlate with an aggressive B-cell lineage in lymphoma patients 3.

Factors Affecting SUV Uptake

  • Several factors can affect FDG uptake by a tumor, including image reconstruction, resolution, and region of interest (ROI) definition parameters 4.
  • The use of intravenous contrast agent in CT scans for PET attenuation correction can result in a bias in attenuation factors, but this bias has been shown to be clinically insignificant in most cases 5, 6.
  • Standardization of acquisition, reconstruction, and ROI methods is preferred for SUV quantification in multi-centre trials to minimize variations in SUV uptake 4.

Clinical Implications

  • High SUV uptake on FDG-PET/CT can predict an aggressive B-cell lymphoma and may have potential therapeutic and prognostic implications 3.
  • PET/CT scans can be used for initial staging of lymphoma patients, and SUV uptake can provide valuable information on tumor aggressiveness and prognosis 3.

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

High SUV uptake on FDG-PET/CT predicts for an aggressive B-cell lymphoma in a prospective study of primary FDG-PET/CT staging in lymphoma.

Annals of oncology : official journal of the European Society for Medical Oncology, 2009

Research

PET/CT with intravenous contrast can be used for PET attenuation correction in cancer patients.

European journal of nuclear medicine and molecular imaging, 2005

Research

Application of intravenous contrast in PET/CT: does it really introduce significant attenuation correction error?

Journal of nuclear medicine : official publication, Society of Nuclear Medicine, 2005

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.